Literature DB >> 15601966

Polymorphisms in PLIN and hypertension combined with obesity and lipid profiles in Han Chinese.

Weili Yan1, Shufeng Chen, Jianfeng Huang, Yan Shen, Boqin Qiang, Dongfeng Gu.   

Abstract

The current study investigated the association between PLIN polymorphisms and the combination of hypertension and obesity (HO) and the related clinical features. The polymorphisms 1237 (T/C), 1243 (C/T), and 1323 (C/G) were genotyped in 503 cases with HO and 511 unrelated controls. No associations between polymorphism 1237 (T/C) or 1243 (C/T) and HO were found. However, total cholesterol (TC) levels were significantly different among genotypes of polymorphism 1243 (p = 0.023, power = 0.55). In male cases, 1243T carriers (TT + CT) had higher TC, high-density lipoprotein-cholesterol, and low-density lipoprotein-cholesterol levels compared with CC homozygote carriers (5.23 +/- 0.88 vs. 4.98 +/- 0.90, p = 0.024; 1.13 +/- 0.23 vs. 1.07 +/- 0.22 mM, p = 0.034; 3.3 +/- 0.78 vs. 3.11 +/- 0.80, p = 0.03, respectively). Additionally, 1243T allele carriers were more prevalent among the subjects with both HO and elevated TC levels (> or =5.2 mM) than those with HO and optimal TC levels (<5.2 mM) (chi(2) = 8.53; p < 0.003; odds ratio, 1.69; 95% confidence interval, 1.19 approximately 2.42). Multiple logistic regression analysis suggested a significant contribution of polymorphism 1243 to the elevated TC levels after controlling for conventional risk factors (odds ratio, 1.48; 95% confidence interval, 1.14 approximately 1.91; p = 0.003). Polymorphism 1243 in the PLIN gene did not seem to be associated with HO but with TC levels in Chinese. The PLIN gene may be involved in human lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15601966     DOI: 10.1038/oby.2004.214

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  9 in total

Review 1.  Update on perilipin polymorphisms and obesity.

Authors:  Caren E Smith; José M Ordovás
Journal:  Nutr Rev       Date:  2012-10       Impact factor: 7.110

2.  Effects of perilipin (PLIN) gene variation on metabolic syndrome risk and weight loss in obese children and adolescents.

Authors:  Sophie Deram; Christiane Y Nicolau; Pablo Perez-Martinez; Isabel Guazzelli; Alfredo Halpern; Bernardo L Wajchenberg; Jose M Ordovas; Sandra M Villares
Journal:  J Clin Endocrinol Metab       Date:  2008-09-23       Impact factor: 5.958

3.  Common variations in perilipin gene, central obesity, and risk of type 2 diabetes in US women.

Authors:  Lu Qi; Cuilin Zhang; Andrew Greenberg; Frank B Hu
Journal:  Obesity (Silver Spring)       Date:  2008-03-06       Impact factor: 5.002

4.  Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome.

Authors:  Toshihide Kawai; Maggie C Y Ng; M Geoffrey Hayes; Issei Yoshiuchi; Takafumi Tsuchiya; Heather Robertson; Nancy J Cox; Kenneth S Polonsky; Graeme I Bell; David A Ehrmann
Journal:  Diabetes Res Clin Pract       Date:  2009-09-25       Impact factor: 5.602

5.  Possible role for ENPP1 polymorphism in obesity but not for INSIG2 and PLIN variants.

Authors:  Armand Peeters; Sigri Beckers; An Verrijken; Ilse Mertens; Luc Van Gaal; Wim Van Hul
Journal:  Endocrine       Date:  2009-04-28       Impact factor: 3.633

Review 6.  Metabolic syndrome pathophysiology: the role of adipose tissue.

Authors:  Jose M Ordovas; Dolores Corella
Journal:  Kidney Int Suppl       Date:  2008-12       Impact factor: 10.545

7.  Sex-Dependent Mediation of Leptin in the Association of Perilipin Polymorphisms with BMI and Plasma Lipid Levels in Children.

Authors:  Claudia Vales-Villamarín; Jairo Lumpuy-Castillo; Teresa Gavela-Pérez; Olaya de Dios; Iris Pérez-Nadador; Leandro Soriano-Guillén; Carmen Garcés
Journal:  Nutrients       Date:  2022-07-26       Impact factor: 6.706

8.  Cross-sectional study of sociodemographic patterning of risk factors for cardiovascular disease in three isolated-based subgroups of the Uyghur population in Xinjiang, China.

Authors:  Jingmei Jiang; Mayila Wufuer; Amuti Simayi; Muyesai Nijiati; Ming Fan; Pengcheng Zhu; Fenghui Chen; Guangliang Shan; Fang Xue; Xiaobing Tian; Feng Li; Lei Hou; Wei Han; Zuheng Cheng; Changchun Qiu
Journal:  BMJ Open       Date:  2013-03-15       Impact factor: 2.692

9.  Insulin resistance: regression and clustering.

Authors:  Sangho Yoon; Themistocles L Assimes; Thomas Quertermous; Chin-Fu Hsiao; Lee-Ming Chuang; Chii-Min Hwu; Bala Rajaratnam; Richard A Olshen
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.